• The appropriate use of statins to lower blood cholesterol remains the main strategy for primary and secondary prevention of atherosclerotic cardiovascular diseases (ASCVD). (physiciansweekly.com)
  • Statin, Ezetimibe, or Fibrate Initiation and Subsequent Use for the Primary and Secondary Prevention of Cardiovascular Diseases among Japanese Patients Aged ≥55 Years: A Nationwide Cohort Study. (bvsalud.org)
  • We aimed to compare the initiation and subsequent use of LMA classes for prevention of cardiovascular diseases . (bvsalud.org)
  • 1. The burden of cardiovascular diseases (CVDs) is increasing rapidly in Africa and this group of diseases is now becoming a public health problem throughout the WHO African Region. (who.int)
  • According to the World Health Report 2001, cardiovascular diseases accounted for 9.2% of the total deaths in the Region in 2000 (more than the deaths caused by malaria) as compared with 8.15% in 1990. (who.int)
  • Cardiovascular diseases are the leading cause of death worldwide except Africa. (wikipedia.org)
  • There are many cardiovascular diseases involving the blood vessels. (wikipedia.org)
  • There are also many cardiovascular diseases that involve the heart. (wikipedia.org)
  • However, context-specific evidence on effective interventions for primary prevention of cardiovascular diseases in resource-poor settings is limited. (biomedcentral.com)
  • The intervention community (Korogocho) will be exposed to an intervention package for primary prevention of cardiovascular disease that comprises awareness campaigns, household screening for cardiovascular diseases risk factors, and referral and treatment of people with high cardiovascular diseases risk at a primary health clinic. (biomedcentral.com)
  • The control community (Viwandani) will continue accessing the usual standard of care for primary prevention of cardiovascular diseases in Kenya. (biomedcentral.com)
  • citation needed] Coronary artery disease (also known as coronary heart disease and ischemic heart disease) Peripheral arterial disease - disease of blood vessels that supply blood to the arms and legs Cerebrovascular disease - disease of blood vessels that supply blood to the brain (includes stroke) Renal artery stenosis Aortic aneurysm There are also many cardiovascular diseases that involve the heart. (wikipedia.org)
  • 2018). Running provides many health benefits, such as lower risks of cardiovascular, metabolic, neurological, pulmonary, and even psychological and psychiatric diseases (Lee et al. (researchgate.net)
  • The Global Burden of Disease Study 1 estimated that in 2010 cardiovascular disease (CVD), including rheumatic heart diseases, hypertensive diseases, ischaemic heart diseases, pulmonary heart disease, other forms of heart disease, cerebrovascular diseases (CBVDs), diseases of arteries and diseases of veins, was the cause of death in approximately 30% of all global deaths. (bmj.com)
  • Cardiovascular (CV) diseases are the leading cause of morbidity and mortality in diabetic patients. (hindawi.com)
  • Cardiovascular diseases (CVD) occurrence were associated with rheumatoid arthritis (RA) and Mediterranean diet (MD), but few studies have been conducted to explore the combined effect. (biomedcentral.com)
  • However, lowering LDL levels is a common clinical practice to reduce oxidation and the risk of major events in patients with cardiovascular diseases (CVD). (hindawi.com)
  • Cardiovascular diseases (CVD) are the leading cause of mortality in the Western population [ 1 ]. (hindawi.com)
  • Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. (epnet.com)
  • As early and effective antiretroviral therapy has become more widespread, HIV has transitioned from a progressive, fatal disease to a chronic, manageable disease marked by elevated risk of chronic comorbid diseases, including cardiovascular diseases (CVDs). (natap.org)
  • In the primary and secondary prevention of these cardiometabolic diseases, exercise intervention is a cornerstone, as it leads to significant reductions in adverse cardiovascular events, hospitalisations and premature death, by improvements in cardiovascular risk factors, exercise capacity and muscle strength, and quality of life. (uhasselt.be)
  • It showed a 13% reduction in four-point major adverse cardiovascular events (MACEs) and a 15% reduction in three-point MACEs, including a 22% reduction in myocardial infarction over about a 5-year follow-up. (medscape.com)
  • Prevention of subsequent cardiovascular events in patients who have had myocardial infarction. (racgp.org.au)
  • Using Framingham risk scoring system, the probability of myocardial infarction or stroke events was calculated for a representative sample population, ages 35 to 69 years, of people at high risk for cardiovascular disease, with a history of coronary heart disease. (ahdbonline.com)
  • For people with coronary or cerebrovascular disease, treatment of moderate-to-severe OSA showed no advantage over usual care for the composite of cardiovascular death, myocardial infarction (MI), stroke, or hospitalization for unstable angina, heart failure, or transient ischemic attack. (medpagetoday.com)
  • For example, anxiety affects more than 25% of the population and is associated with increased development of unstable angina, myocardial infarction, ventricular arrhythmia, cardiovascular mortality, heart failure and stroke. (acc.org)
  • The purpose of this document is to provide a thorough review of the existing evidence on HIV-associated CVD, in particular atherosclerotic CVD (including myocardial infarction and stroke) and heart failure, as well as pragmatic recommendations on how to approach CVD prevention and treatment in HIV in the absence of large-scale randomized controlled trial data. (natap.org)
  • The primary endpoint was a composite of myocardial infarction, other acute coronary syndrome, stroke, heart failure, or cardiovascular-related death. (medscape.com)
  • Centers for Disease Control and Prevention. (cdc.gov)
  • The Centers for Disease Control and Prevention (CDC) estimate that one in five Americans will experience a mental illness in a given year and over 50% will have an encounter with a mental illness or disorder in their lifetime. (acc.org)
  • The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. (cdc.gov)
  • Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in women. (researchgate.net)
  • Cardiovascular disease, especially coronary heart disease and cerebrovascular disease, is a leading cause of mortality and morbidity in women globally. (researchgate.net)
  • This review details the findings surrounding the impact of running on various health outcomes and premature mortality, highlights plausible underlying mechanisms linking running with chronic disease prevention and longevity, identifies the estimated additional life expectancy among runners and other active individuals, and discusses whether there is adequate evidence to suggest that longevity benefits are attenuated with higher doses of running. (researchgate.net)
  • Association of Spicy Chilli Food Consumption With Cardiovascular and All-Cause Mortality: A Meta-Analysis of Prospective Cohort Studies. (monash.edu)
  • Cardiovascular disease (CVD) is a leading cause of mortality. (bmj.com)
  • It's important to note that there is evidence that even a negative outlook, or lack of sense of purpose, is associated with an increased risk of cardiovascular disease and all-cause mortality. (acc.org)
  • Furthermore, cardiovascular comorbidities have been determined as key factors of mortality for SARS-CoV-2 infected patients, which present high blood levels of cardiac-specific proteins troponin I and/or T, indicative signs of hypoxia, tachyarrhythmia, myocarditis, and myocardial injury ( 3 - 8 ). (frontiersin.org)
  • Case studies performed on COVID-19 patients, and autopsies conducted on those who died due to cardiovascular complications such as stroke and acute coronary syndromes, point to thrombotic disease as a critical factor of mortality in severe cases of COVID-19 ( 9 - 12 ). (frontiersin.org)
  • more recently, lowering lipid concentrations by the use of statins (HMG coA-reductase inhibitors) has been proven to reduce cardiovascular and total mortality and these drugs are now recommended as first-line therapy in both primary and secondary CVD prevention. (unboundmedicine.com)
  • the total mortality regarding cardiovascular causes an outcome that was not observed with the use of ARBs. (intechopen.com)
  • The results suggest a need for greater efforts to heighten public awareness and to improve patient management to prevent unnecessary cardiovascular-disease-related morbidity and mortality, according to the group. (medscape.com)
  • Although the evidence points to a reduction in cardiovascular events when statins are used for primary prevention, the absolute risk reduction is often small and the studies have not shown a reduction in all-cause mortality. (medscape.com)
  • Macrovascular disease constitutes the major cause of diabetes mellitus mortality, with 80% of patients having and/or dying of cardiovascular, cerebrovascular or peripheral arterial disease. (who.int)
  • Many trials, however, have shown a benefit with respect to cardiovascular events, morbidity and mortality when coexistent hypertension is treated. (who.int)
  • Therefore, aggressive strategies aimed at identifying and treating high blood pressure in patients with diabetes should lead to substantial reduction in the risk of cardiovascular morbidity and mortality. (who.int)
  • People with diabetes and hypertension have a two-fold increased risk of cardiovascular mortality compared to patients with diabetes alone. (who.int)
  • One is a cardiovascular outcomes trial called PREVAIL . (medscape.com)
  • NCT03626662 ), the primary outcome was safety and tolerability, and the secondary outcomes were the change in Lp(a) concentrations and olpasiran pharmacokinetic parameters. (nature.com)
  • Primary outcomes comparing pre- and post-, and operational data will be analyzed descriptively and "impact" of the intervention will be calculated using double-difference methods. (biomedcentral.com)
  • Secondary outcomes were the proportion of clients with elevated risk that had follow-up actions recorded. (frontiersin.org)
  • Conducting omega-3 clinical trials with cardiovascular outcomes: Proceedings of a workshop held at ISSFAL 2014. (tidsskriftet.no)
  • PURPOSE Primary care practices in the United Kingdom have received substantial financial rewards for achieving standards set out in the Quality and Outcomes Framework since April 2004. (annfammed.org)
  • 1 Introduced in 2004, the UK Quality and Outcomes Framework (QOF) is arguably the most comprehensive national primary care pay-for-performance (P4P) scheme in the world. (annfammed.org)
  • Part of the leading thinking of this was that CPAP indeed would reduce cardiovascular disease outcomes. (medpagetoday.com)
  • While she cited more than 15 clinical trials that "have consistently demonstrated improvement in blood pressure and other studies that have pointed towards benefit of other cardiovascular endpoints" with apnea treatment, Magnus Ohman, MBBS , of the Duke Clinical Research Institute in Durham, N.C., noted that only SAVE and SERVE-HF have looked at hard clinical outcomes -- and both went at least numerically in the wrong direction. (medpagetoday.com)
  • Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 2029. (monash.edu)
  • The association between psychological health and cardiovascular outcomes is highlighted in a scientific statement encouraging a more holistic model for patient care from the American Heart Association. (acc.org)
  • AHA/ASA recommends against the use of the term "hemorrhagic stroke" because it may refer to both hemorrhage that occurs after CNS infarction or primary ICH or SAH. (medscape.com)
  • In October 2014, the American Heart Association and American Stroke Association (AHA/ASA) released an update of their 2011 Guidelines for the Primary Prevention of Stroke. (medscape.com)
  • Antiplatelet agents are effective in primary and secondary prevention of arterial thrombosis (cardiovascular events, ischaemic stroke, and peripheral arterial occlusive disease). (hindawi.com)
  • Reductions in cardiovascular and stroke events reported in clinical trials with aggressive statin therapy were applied to these cohorts. (ahdbonline.com)
  • So a trial of CPAP should still be offered for OSA patients with heart disease or prior stroke, albeit not with the sole purpose of reducing future cardiovascular events, concluded an accompanying editorial by Babak Mokhlesi, MD , of the University of Chicago, and Najib T. Ayas, MD, MPH , of the University of British Columbia in Vancouver. (medpagetoday.com)
  • Statins are recommended for secondary prevention in people who have had coronary surgery, MI, stroke , or peripheral artery disease and have an LDL-cholesterol greater than 2.5 mmol/L plus additional risk factors. (medscape.com)
  • The appropriateness of the use of statins for the secondary and primary prevention of atherosclerotic cardiovascular disease: a cross-sectional study from Jordan. (physiciansweekly.com)
  • Dyslipidemia is a common condition coexisting with type 2 diabetes and a clear risk factor for the development of atherosclerotic cardiovascular disease (ASCVD). (medscape.com)
  • The majority of patients, 550 (73.1%), used statins for secondary prevention. (physiciansweekly.com)
  • A notable sex difference in terms of persistence rates was observed only for statins of secondary prevention . (bvsalud.org)
  • The restarting rates were similar between prevention settings approximately 50-60% for statins and 30-40% for ezetimibe and fibrates 1 year after first discontinuation. (bvsalud.org)
  • Subjects Patients aged 30-84 years who were free of cardiovascular disease and not taking statins between 1 January 1994 and 30 April 2010: 2 343 759 in the derivation dataset, and 1 267 159 in the validation dataset. (bmj.com)
  • Colesevelam ([see symbol in text] Cholestagel--Genzyme), a new bile acid sequestrant, is licensed for use in the management of primary hypercholesterolaemia, either as monotherapy when statins are not tolerated or considered inappropriate, or as an adjunct to statin therapy in patients who are not adequately controlled on a statin alone. (unboundmedicine.com)
  • Nevertheless, the study did highlight a large gap between recommended and actual preventive therapy with statins, even in people at the highest risk of a cardiovascular event, Balder told heart wire . (medscape.com)
  • The researchers concluded from these findings that statins would offer no benefit in the primary prevention of cardiovascular disease (CVD) in adults over age 65. (medscape.com)
  • Statins certainly have been shown time and again to reduce the incidence of cardiovascular events, but there is a bigger picture-a broader perspective-that often gets bumped aside in our focus on evidence-based medicine. (medscape.com)
  • Available antiplatelet agents, such as cyclooxygenase-1 (COX-1) inhibitors (aspirin), ADP P2Y 12 receptor antagonists, and GP IIb/IIIa receptor inhibitors, are effective and save in the treatment and prevention of thrombotic events, these drugs interfere with the platelet activation process, including adhesion, release, and aggregation. (hindawi.com)
  • Aspirin for primary prevention of cardiovascular disease? (bmj.com)
  • 1 , 3 , 4 , 5 However, there has been some uncertainty about the place of aspirin for the primary prevention of cardiovascular events. (bmj.com)
  • 7 , 8 Here we consider the place of low-dose aspirin in primary prevention of CVD. (bmj.com)
  • In this sense, the antithrombotic properties of aspirin make it a plausible drug for thrombotic disease prevention, the efficacy of which requires to be validated in COVID-19 patients. (frontiersin.org)
  • hypertension, smoking, obesity, physical inactivity, unhealthy diet, high cholesterol, excessive alcohol consumption and diabetes .5,6 These risk factors are amenable to prevention or control through the adoption of appropriate health policies by governments which encourage the adoption of healthy lifestyles by individuals. (who.int)
  • There is little information on the prevalence of hypertension and other modifiable cardiovascular risk factors in community-dwelling elderly in the Netherlands and the potential impact of improving antihypertensive treatment on major cardiovascular events. (nih.gov)
  • The prevalence of hypertension and other cardiovascular risk factors are described for participants with and without a history of cardiovascular disease (CVD). (nih.gov)
  • Hypertension and other cardiovascular risk factors are very common in elderly subjects. (nih.gov)
  • The burden of cardiovascular disease is rising in sub-Saharan Africa with hypertension being the main risk factor. (biomedcentral.com)
  • Platelets have a "key role" in atherogenesis and its thrombotic complications in subjects with DM [ 3 ], and the concomitant presence of multiple "classical" cardiovascular risk factors (arterial hypertension, cigarette smoking, and hyperlipidemia) in diabetic subjects contributes to enhanced atherothrombotic risk. (hindawi.com)
  • Primary and secondary hypertension. (medlineplus.gov)
  • Cardiovascular (CV) risk factors such as hypercholesterolemia, hyperglycaemia, obesity, hypertension, smoking, and aging promote vascular inflammation and endothelial activation [ 7 - 9 ]. (hindawi.com)
  • The possibility of secondary hypertension should be kept in mind and appropriate laboratory investigation undertaken as indicated. (who.int)
  • Multiple metabolic abnormalities associated with insulin resistance and increased cardiovascular risk such as dyslipidaemia, obesity and hypertension are already present at diagnosis. (who.int)
  • Understanding barriers and facilitators to adherence to secondary prevention for CVD at multiple health system levels may inform policy. (bmj.com)
  • Objectives To conduct a systematic review of barriers and facilitators to adherence/persistence to secondary CVD prevention medications at health system level. (bmj.com)
  • Conclusions High-quality evidence on health system barriers and facilitators to adherence to secondary prevention medications for CVD is lacking, especially for low-income settings. (bmj.com)
  • Other cardiovascular injuries associated with COVID-19 are venous and arterial thrombosis, and venous thromboembolism (VTE). (frontiersin.org)
  • Power calculations for a definitive trial were performed on the different outcome measures to identify the most appropriate primary outcome measure. (bmj.com)
  • The intervention was developed with significant stakeholder involvement, a range of primary outcome measures were tested for suitability and the process for collecting resource utilisation data was identified. (bmj.com)
  • Our analysis models the cost impact of aggressive statin therapy for a commercially insured cohort of members at high risk for secondary events from CVD as a result of a history of CHD. (ahdbonline.com)
  • AMSTERDAM, THE NETHERLANDS - A "shocking" 80% of individuals in a large Dutch cohort who were eligible for primary prevention with statin therapy reported not taking the drug, a new analysis has shown [ 1 ] . (medscape.com)
  • Despite strong evidence that statin therapy can reduce cardiovascular events, studies have suggested that many eligible patients may not be taking the preventive therapy, Balder said. (medscape.com)
  • Of the 3268 participants who were deemed eligible for primary prevention with statin therapy, only 753 patients (23%) reported taking a statin. (medscape.com)
  • Of the 1302 participants who were eligible for secondary prevention with statin therapy, 899 participants (69%) reported taking a statin. (medscape.com)
  • Despite the importance of absolute cardiovascular risk assessment (CVRA) as a screening and early intervention tool, few studies have reported its use within the Australian Indigenous primary health care (PHC) sector. (frontiersin.org)
  • This is because age has such a dominant effect in calculating absolute cardiovascular risk. (bmj.com)
  • Primary prevention to reduce the risk of ASCVD is an important goal for PLWH. (natap.org)
  • The development of cardiometabolic conditions in pregnancy, such as gestational diabetes mellitus and hypertensive disorders of pregnancy, portend an increased risk of future cardiovascular disease. (researchgate.net)
  • Although clinical treatment of COVID-19 patients focuses on the pulmonary complications and acute respiratory distress syndrome (ARDS), medical reports have also pointed toward the severe deterioration of the patient's state of health due to cardiovascular complications. (frontiersin.org)
  • Primary and secondary prevention of cardiovascular complications is essential to the management of type 2 diabetes. (medscape.com)
  • The role of chronic administration of antiplatelet drugs in primary prevention of arterial vascular events is known to be less clear than in secondary prevention, and, also in diabetic patients, the decision to give primary prophylaxis should be taken on an individual-patient basis, after a careful evaluation of the balance between the expected benefits and the risk of major bleedings. (hindawi.com)
  • Although, currently, treatment has proven useful in reducing vascular events, diabetic patients continue to have a higher risk of adverse cardiovascular events compared with those in nondiabetic patients. (hindawi.com)
  • This paper reviews the role of currently available antiplatelet drugs in primary and secondary prevention of vascular events in diabetic patients and the limitations of these drugs, and it discusses the role of novel and more potent antiplatelets and of new agents currently under clinical development. (hindawi.com)
  • Large clinical trials have shown that antiplatelet agents are effective in the prevention of recurrent cardiovascular events in diabetes. (hindawi.com)
  • Prevention of cardiovascular events in patients who are at high risk of cardiovascular disease. (racgp.org.au)
  • The target population consists of working-age people who are considered high-risk for cardiovascular disease events because of a history of coronary heart disease. (ahdbonline.com)
  • Aggressive low-density lipoprotein cholesterol-lowering therapy for working-age people at high risk for cardiovascular events and with a history of heart disease appears to have a significant potential to reduce the rate of clinical events and is cost-neutral for payers. (ahdbonline.com)
  • This approach is established for the secondary prevention of recurrent vascular events. (bmj.com)
  • Despite clear guidelines and multiple countrywide efforts to improve the care of patients with cardiovascular disease, adherence to the guidelines remains a major challenge in the Netherlands, they state. (medscape.com)
  • 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (medlineplus.gov)
  • Using the Dutch clinical guidelines, patients are eligible for primary-prevention with a statin if their LDL-cholesterol is greater than 2.5 mmol/L (97 mg/dL) and they have additional risk factors with a medium or high 10-year risk of cardiovascular disease (or a total cholesterol-to-HDL-cholesterol ratio greater than 8). (medscape.com)
  • He has published regarding the clinical use of measuring lipoprotein(a) in predicting risk of cardiovascular disease in different populations and regarding the need for an integrated approach to cardiovascular disease modification. (rochester.edu)
  • The first set of risk factors for CVDs, which include family or personal history of cardiovascular disease, race ,2 gender 3 and age ,4 are not modifiable by interventions. (who.int)
  • Methods Included studies reported effects of health system level factors on adherence/persistence to secondary prevention medications for CVD (coronary artery or cerebrovascular disease). (bmj.com)
  • The primary aim of this systematic review is to determine the efficacy of primary and secondary. (researchgate.net)
  • Cardiovascular disease is the leading cause of premature death and a major cause of disability in the UK. (bmj.com)
  • According to the WHO cardiometabolic disease (combination of metabolic and cardiovascular disease) is worldwide the most important cause of premature death. (uhasselt.be)
  • 1 Poor mental health can have an unseen impact on the cardiovascular system - even beyond stress-induced, or takotsubo, cardiomyopathy - leading to an increase in cardiovascular risk and comorbidities downstream. (acc.org)
  • The primary event rate was 8.1% without a statin and 6.3% with a statin, an absolute risk reduction with a statin of 1.8% (P = .13). (medscape.com)
  • Despite proven cost-effectiveness of medications for secondary prevention of cardiovascular disease, adherence is suboptimal. (bmj.com)
  • However, these factors are either already taken care of through other initiatives or programmes (reproductive health, HIV/AIDS prevention and control), need more research or are not amenable to cost-effective preventive interventions. (who.int)
  • We have special training in diagnosing and treating the full range of conditions, and we emphasize prevention strategies designed to keep you in the best possible health. (emersonhospital.org)
  • Jonathan Greene, MD, discusses why cholesterol is such a core component in cardiovascular health. (emersonhospital.org)
  • Around one-fifth of the health disparity is caused by cardiovascular disease (CVD). (frontiersin.org)
  • Cardiovascular disease (CVD), largely driven by the combined effect of several modifiable risk factors such as smoking and obesity, is the leading contributor accounting for one-fifth of the health gap ( 1 ). (frontiersin.org)
  • Strong primary care is widely accepted to be a prerequisite for effective, efficient, equitable health systems and to lead to better population health. (annfammed.org)
  • Given the substantial human and animal data that have consistently documented links between obstructive sleep apnea and cardiovascular health, we suspect it may be the latter. (medpagetoday.com)
  • Screening tools like the Generalized Anxiety Disorder-7 and the PHQ-2, used for anxiety and depression respectively, can be used routinely in the outpatient and inpatient settings to help identify patients who would benefit from treatment, which would also lead to improving their cardiovascular health. (acc.org)
  • In their recent review of the evidence examining the impact of saturated fat on health, the Scientific Advisory Committee on Nutrition (SACN) concluded that reducing saturated fat lowers the risk of cardiovascular disease (CVD) and coronary heart disease (CHD), lowers total, LDL-C and HDL-C and improves indicators of glycaemic control. (heartuk.org.uk)
  • Novel research will be presented including new insights into the connections between diet, exercise, and cardiovascular health. (escardio.org)
  • The optimal diet for cardiovascular health is controversial. (escardio.org)
  • Its mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention. (escardio.org)
  • Research: The primary and secondary prevention of cardiovascular disease through public health measures and medical practice redesign as well as the investigation of pathophysiologic mechanisms by which disease develops. (rochester.edu)
  • While lifestyle modification is recommended for CVD prevention, there are no systematic reviews evaluating the effectiveness of interventions targeted to women. (researchgate.net)
  • CSS contributes to the upregulation of metabolic coagulation pathways resulting in damage to the endothelium, and therefore to the cardiovascular system ( 14 - 16 ). (frontiersin.org)
  • Stay tuned for the hottest science in the prevention of heart disease at ESC Preventive Cardiology 2021, an online scientific congress of the European Society of Cardiology (ESC). (escardio.org)
  • 1 National policies now support targeting of interventions to reduce risk of cardiovascular disease among high risk patients. (bmj.com)
  • Conclusions Our model can be used to estimate the impact of primary prevention interventions on life expectancy and can assess the impact of interventions on inequalities. (bmj.com)
  • However, the desired exercise type, intensity and dose, to target various crucial organs/tissues such as skeletal muscle, adipose tissue, and the cardiovascular system, remains to be determined in patients with obesity, diabetes or heart disease. (uhasselt.be)
  • Due attention should be given to other coexisting cardiovascular risk factors - such as obesity and dyslipidaemia - and appropriate management of these conditions should be instituted. (who.int)
  • Clinicians should also emphasize to their patients the mind-body connection as a crucial component of preventing and managing cardiovascular disease. (acc.org)
  • Cochrane Abstracts , Evidence Central , evidence.unboundmedicine.com/evidence/view/Cochrane/436827/all/Polyunsaturated_fatty_acids_for_the_primary_and_secondary_prevention_of_cardiovascular_disease. (unboundmedicine.com)
  • 1. von Schacky C. Omega-3 Fatty Acids in Cardiovascular Disease - an Uphill Battle. (tidsskriftet.no)
  • His sub-focus is the role of fatty acids and cardiovascular disease. (rochester.edu)
  • This also results in elevated cortisol levels, causing insulin resistance, impaired glucose tolerance, dyslipidemia and ultimately cardiovascular disease. (acc.org)
  • Therefore, our understanding of CVD pathogenesis, prevention, and treatment in HIV relies on large observational studies, randomized controlled trials of HIV therapies that are underpowered to detect CVD end points, and small interventional studies examining surrogate CVD end points. (natap.org)
  • Overall, 63% of subjects have two or more cardiovascular risk factors amenable to treatment. (nih.gov)
  • Up-to-the-minute scientific evidence on electronic cigarettes will be highlighted including effects on cardiovascular and respiratory function, prevalence of usage, and legislation. (escardio.org)
  • INT RODUCTIO N: Th e eld erly h ypert en si ve pa ti ent s of ten h aveincreased prevalence of cardiometabolic risk factors and their attendantco-morbidities. (bvsalud.org)
  • A greater understanding of the rates of modifiable CVD risk factors in women with a history of HDP can inform CVD prevention priorities in. (researchgate.net)
  • Compelling evidence supports a causal role for lipoprotein(a) (Lp(a)) in cardiovascular disease. (nature.com)
  • Cardiovascular disease ( CVD ) is any disease involving the heart or blood vessels . (wikipedia.org)
  • I'm Jay Shubrook, a primary care professor at Touro University of California, a family physician, and a primary care diabetologist. (medscape.com)
  • Cross-sectional analysis of Dutch community-dwelling subjects aged 70-78 years without dementia who were included in the cluster randomized preDIVA trial (Prevention of Dementia by Intensive Vascular care). (nih.gov)
  • Emerson Cardiovascular Associates provides comprehensive care, including most of the tests that our patients require. (emersonhospital.org)
  • This article reviews the growing evidence for the impact of the framework on the quality of primary medical care. (annfammed.org)
  • It was one component in the reorganization of primary care resulting from a new General Medical Services contract for general practitioners that led to a practice-based, rather than practitioner-based, contract and investment to reward quality of care through both fixed and performance-related funding streams. (annfammed.org)
  • In 2009-2010, practices in England achieved an average of 937 points, with a range in each of the 152 primary care trusts from 878 to 972 points. (annfammed.org)
  • It also includes sports cardiology, primary care, epidemiology and population science, basic and translational research, and rehabilitation after an event. (escardio.org)
  • scintigraphy, echography or stress MRI) - wishing diagnostic care and primary prevention of coronary disease. (who.int)